Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells.

Genetic diseases are illnesses caused by abnormalities in genes or chromosomes, including hemophilia, Huntington’s disease, and cancer. They can be caused by both genetic and environmental predispositions. Small interfering RNA (siRNA) is a powerful tool to inhibit gene function because it can be easily applied to any therapeutic target, providing revolutionary potency and selectivity of improved targeted therapeutics.[1] However, poor intracellular uptake, instability, and non-specific immune stimulation are obstacles associated with current methods of siRNA oligonucleotide delivery. Therefore, developing a stable, highly effective siRNA delivery system with optimal cellular integration and low toxicity is of utmost importance. In the present study, we successfully use a nanocomplex assembly of polyethylenimine (PEI) and mesoporous silica nanoparticles (MSNs) to protect and deliver siRNA into human cells, and effectively shutdown both exogenous and endogenous gene signals.

[1]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Marshall,et al.  Biologic therapies for advanced pancreatic cancer , 2008, Expert review of anticancer therapy.

[3]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[4]  Yanli Fu,et al.  Enhanced local delivery with reduced systemic toxicity: Delivery, delivery, and delivery , 2006, Gene Therapy.

[5]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[6]  Avelino Corma,et al.  Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA. , 2009, The journal of physical chemistry. B.

[7]  M. Nango,et al.  Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine , 2000, Gene Therapy.

[8]  D. Piwnica-Worms,et al.  In vivo RNA Interference–Mediated Ablation of MDR1 P-Glycoprotein , 2005, Clinical Cancer Research.

[9]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[10]  P. Ortega,et al.  Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[12]  Saji George,et al.  Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.

[13]  John J. Rossi,et al.  The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.

[14]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. , 2009, Small.

[15]  Monty Liong,et al.  Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. , 2007, Small.

[16]  Yuen A. Lau,et al.  Mechanised nanoparticles for drug delivery. , 2009, Nanoscale.

[17]  A. Mikos,et al.  Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency , 1999, Gene Therapy.

[18]  Jindrich Kopecek,et al.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. , 2002, Advanced drug delivery reviews.

[19]  Cari D. Pentecost,et al.  Construction of a pH-driven supramolecular nanovalve. , 2006, Organic letters.

[20]  Jeffrey I Zink,et al.  Light-activated nanoimpeller-controlled drug release in cancer cells. , 2008, Small.

[21]  Iseult Lynch,et al.  Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. , 2008, Nano letters.

[22]  Monty Liong,et al.  Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells , 2007, Nanobiotechnology : the journal at the intersection of nanotechnology, molecular biology, and biomedical sciences.

[23]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[24]  R. Toes,et al.  Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion. , 2004, Critical reviews in oncology/hematology.

[25]  Douglas C. Friedman,et al.  pH-responsive mechanised nanoparticles gated by semirotaxanes. , 2009, Chemical communications.

[26]  Brian J. Melde,et al.  Hybrid Inorganic–Organic Mesoporous Silicates—Nanoscopic Reactors Coming of Age , 2000 .

[27]  Kemin Wang,et al.  In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. , 2008, Analytical chemistry.

[28]  Myung-Haing Cho,et al.  Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. , 2008, International journal of pharmaceutics.

[29]  Monty Liong,et al.  Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery. , 2009, Journal of the American Ceramic Society. American Ceramic Society.

[30]  Victor S-Y Lin,et al.  A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. , 2004, Journal of the American Chemical Society.

[31]  D. V. Svintradze,et al.  Fiber molecular model of atelocollagen-small interfering RNA (siRNA) complex. , 2005, International journal of biological macromolecules.

[32]  Michelle Bradbury,et al.  Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. , 2009, Nano letters.

[33]  Galen D. Stucky,et al.  MESOPOROUS SILICATE SEQUESTRATION AND RELEASE OF PROTEINS , 1999 .

[34]  F. Yuan,et al.  Systemic virus dissemination during local gene delivery in solid tumors and its control with an alginate solution , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[35]  J. F. Stoddart,et al.  Mesostructured Silica Supports for Functional Materials and Molecular Machines , 2007 .

[36]  Kitae E. Park,et al.  Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. , 2009, Molecular pharmaceutics.

[37]  Jeffrey A. Engelman,et al.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.

[38]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[39]  J. Fraser Stoddart,et al.  Mesostructured multifunctional nanoparticles for imaging and drug delivery , 2009 .

[40]  E. Wagner,et al.  Design and gene delivery activity of modified polyethylenimines. , 2001, Advanced drug delivery reviews.

[41]  H. Junginger,et al.  PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium , 2004, European Journal of Pharmaceutics and Biopharmaceutics.

[42]  T. Bein,et al.  Porous thin films of functionalized mesoporous silica nanoparticles. , 2008, ACS nano.

[43]  M. Vallet‐Regí,et al.  MCM-41 Organic Modification as Drug Delivery Rate Regulator , 2003 .

[44]  F M Muggia,et al.  Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  Sha Jin,et al.  Nanoparticle-mediated gene delivery. , 2009, Methods in molecular biology.

[46]  V. S. Lin,et al.  Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.

[47]  T. Schiestel,et al.  Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. , 2000, International journal of pharmaceutics.

[48]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[49]  R. Samulski,et al.  Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.